NCT04367987

Brief Summary

Heart rate variability reflects the autonomic nervous system on the intrinsic activity of sinus node cells. Sympathetic hyperactivity is an adaptation to stress, while parasympathetic hyperactivity is present at rest. Thus, any variability in the heart frequency rate reflects variations in sympathetic and parasympathetic components in the autonomic nervous system. Failure to return to normal or a reduction in the variability of the heart rate in the postoperative period is correlated with complications in colorectal surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
117

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 29, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

June 17, 2020

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

March 21, 2022

Status Verified

August 1, 2021

Enrollment Period

4 years

First QC Date

April 27, 2020

Last Update Submit

March 18, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Rate of variability of the heart rate between Day-1 to Day 7

    Measured by power spectral density; ratio of the high to low frequencies

    Day 7

  • Correlation between the rate of variability of the heart rate between Day-1 to Day 7and anastomotic fistula diagnosed according to Center for Diseases Control criteria after scheduled colorectal surgery

    Abdominal-pelvic imagery

    Hospital discharge (maximum Day 7)

  • Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and peri-anastomotic fluid collections after scheduled colorectal surgery

    Abdominal-pelvic imagery

    Hospital discharge (maximum Day 7)

Secondary Outcomes (12)

  • Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of intra abdominal abscess

    Hospital discharge (maximum Day 7)

  • Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of gut wall abscess

    Hospital discharge (maximum Day 7)

  • Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of pneumonia

    Hospital discharge (maximum Day 7)

  • Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of urinary tract infection

    Hospital discharge (maximum Day 7)

  • Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of central venous catheter infection

    Hospital discharge (maximum Day 7)

  • +7 more secondary outcomes

Study Arms (1)

Patients undergoing colorectal surgery

Diagnostic Test: Heart Rate Variability

Interventions

Heart Rate VariabilityDIAGNOSTIC_TEST

Heart rate and RR interval Post-anonymized analysis of heart rate variability using the KUBIOS software

Patients undergoing colorectal surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients undergoing scheduled colorectal resection or operated on in the digestive surgery department of the CHU Nîmes

You may qualify if:

  • Patients operated for a scheduled colorectal resection due to cancer, diverticulitis, or Chronic Inflammatory Bowel Disease,
  • American Society of Anesthesiologists score 1-2
  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan

You may not qualify if:

  • Patient taking antidepressants, antipsychotics, antihypertensive beta blocker type, anti-arythmic or oral contraception
  • Uncontrolled diabetes or associated with a neuropathy
  • Arrhythmias and conduction disturbances, , coronaropathy and heart failure, kidney failure
  • Neuropathies
  • Pacemaker or defibrillator
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nimes

Nîmes, France

RECRUITING

Study Officials

  • Martin Bertrand

    CHU Nimes

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2020

First Posted

April 29, 2020

Study Start

June 17, 2020

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

March 21, 2022

Record last verified: 2021-08

Locations